Who is sponsoring NCT06112912?

NCT06112912 is sponsored by Mathematica Policy Research, Inc..

What drugs are being tested in NCT06112912?

Interventions in NCT06112912: REAL Essentials Advance.

What condition does NCT06112912 study?

NCT06112912 studies Components of REAL Essentials.

Is NCT06112912 still recruiting?

NCT06112912 is currently completed. Last updated 2 November 2023.

Last reviewed 2023-11-02 · How we verify

NCT06112912: REA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Components Study of REAL Essentials

Completed Last updated 2 November 2023

What this trial tests

trial testing REAL Essentials Advance in Components of REAL Essentials in 1,301 participants. Completed in 30 June 2023.

Timeline

1 January 2022

Primary endpoint
30 December 2022

30 June 2023

Quick facts

Lead sponsor	Mathematica Policy Research, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,301
Start date	1 January 2022
Primary completion	30 December 2022
Estimated completion	30 June 2023
Sites	1 location across United States

Drugs / interventions tested

REAL Essentials Advance

Conditions studied

Components of REAL Essentials — all drugs for Components of REAL Essentials →

Sponsor

Mathematica Policy Research, Inc.

Who can join

Adults 14 to 19, any sex, with Components of REAL Essentials. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Components Study of REAL Essentials (REA) is a descriptive implementation and outcome study. This study aims to identify the components that matter most for promoting positive health behaviors and outcomes among adolescents. The study will examine a variety of components to determine which are most influential in predicting participant outcomes. In addition, the study will measure youth engagement in programming from various perspectives and examine the role of engagement as an intermediary factor to achieving youth outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Strategies for Identifying Core Components of Programs: an Exploratory Descriptive Component Case Study of a Teen Pregnancy Prevention Program.
Cole R, Knab J, Forrester E. · · 2026 · PMID 41665797 · DOI 10.1007/s11121-026-01881-8

Verify or expand the search:

Other Mathematica Policy Research, Inc. trials

Trials by the same sponsor.

NCT06694376 — Understanding and Expanding the Reach of Home Visiting (HV-REACH) Project · not yet recruiting
NCT06329778 — Home-Based Child Care Toolkit for Nurturing School-Age Children Study · completed
NCT05730075 — The Home-Based Child Care Toolkit for Nurturing School-Age Children Pilot Study · completed
NCT05258994 — Early Care and Education Leadership Study: Descriptive Study · completed
NCT05146362 — Vermont RETAIN Impact Evaluation · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06112912 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mathematica Policy Research, Inc.
Last refreshed: 2 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06112912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing